Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Current Assets (2019 - 2025)

Pulmonx (LUNG) has disclosed Current Assets for 6 consecutive years, with $120.0 million as the latest value for Q2 2025.

  • Quarterly Current Assets fell 17.88% to $120.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $120.0 million through Jun 2025, down 17.88% year-over-year, with the annual reading at $136.2 million for FY2024, 9.42% down from the prior year.
  • Current Assets for Q2 2025 was $120.0 million at Pulmonx, down from $136.2 million in the prior quarter.
  • The five-year high for Current Assets was $227.6 million in Q3 2021, with the low at $120.0 million in Q2 2025.
  • Average Current Assets over 5 years is $167.9 million, with a median of $159.7 million recorded in 2022.
  • The sharpest move saw Current Assets decreased 18.77% in 2022, then fell 9.42% in 2024.
  • Over 5 years, Current Assets stood at $208.0 million in 2021, then fell by 18.77% to $169.0 million in 2022, then decreased by 10.97% to $150.4 million in 2023, then fell by 9.42% to $136.2 million in 2024, then dropped by 11.91% to $120.0 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $120.0 million, $136.2 million, and $146.2 million for Q2 2025, Q4 2024, and Q2 2024 respectively.